HomeArticleWeekly Nephrology Journal Summary — 3–9 October 2026

Weekly Nephrology Journal Summary — 3–9 October 2026

NEPHROHUB

Weekly Nephrology Journal Summary — 3–9 October 2026

Verified sources | Concise clinical review

Educational disclaimer. This AI-assisted literature summary is for education only. It is not medical advice and does not replace the original publication, guidelines, regulatory information, or individualized assessment.
Editorial disclosure. This review is selective rather than systematic. Dates and direct DOI links were verified for 3–9 October 2026; records without sufficient verifiable detail were excluded.
Lancet

Understanding peripheral arterial disease in the current era.

2026 Oct | Review | DOI: 10.1016/S0140-6736(26)00846-9

AI Clinical Summary

PAD remains underdiagnosed and undertreated; the review emphasizes interdisciplinary recognition and early diagnosis, while noting persistent care disparities.

Clinical relevance: High
View original article →
American Journal of Nephrology

The Cardiorenal Protective Effects of Low-dose Tolvaptan in Peritoneal Dialysis Patients with Volume Overload.

2026 Oct | Randomized controlled trial | DOI: 10.1159/ajn/ablag013

AI Clinical Summary

Low-dose tolvaptan reduced overhydration and increased urine volume, with apparent residual GFR and LVEF benefits over 6 months. Small, single-center data require confirmation.

Clinical relevance: High
View original article →
BMC Nephrology

Acute kidney injury at a tertiary nephrology referral center: predictors of renal recovery and in-hospital mortality.

2026 Oct | Prospective observational study | DOI: 10.1186/s12882-026-05296-z

AI Clinical Summary

Among 839 patients, AKI incidence was 39.3% and mortality 17.3%. Vasopressors, KDIGO stage 3, and dialysis predicted poorer outcomes; single-center data limit generalizability.

Clinical relevance: Moderate
View original article →
AJKD

Barriers to and Facilitators of the Adoption of Peritoneal Dialysis.

2026 Oct | Systematic review | DOI: 10.1053/j.ajkd.2026.07.013

AI Clinical Summary

Fear of infection, poor education, and hemodialysis-centric policy hinder PD adoption; autonomy and structured support facilitate it. Included studies were heterogeneous.

Clinical relevance: High
View original article →
NEJM

Vasopressors or Fluids in Early Septic Shock.

2026 Oct | Multicenter randomized controlled trial | DOI: 10.1056/NEJMoa2516225

AI Clinical Summary

Restricted fluids with early vasopressors did not improve 90-day survival versus liberal fluids, although it reduced fluid exposure and pulmonary edema.

Clinical relevance: High
View original article →
Kidney360

Heavy Numbers: When Obesity Tips the Balance between Creatinine- and Cystatin C-Based eGFR.

2026 Oct | Observational cohort study | DOI: 10.34067/KID.0000001392

AI Clinical Summary

In BMI ≥35 kg/m², creatinine- and cystatin-C eGFR frequently disagreed, reclassifying KDIGO G stage in 43%. Measured GFR was unavailable.

Clinical relevance: High
View original article →
Pediatric Nephrology

Characteristics and clinical outcomes of Denys-Drash syndrome.

2026 Oct | Systematic review of case reports and series | DOI: 10.1007/s00467-026-07552-8

AI Clinical Summary

Among 107 patients, WT1 mutations, Wilms tumor, and kidney failure were frequent, supporting early genetic diagnosis and surveillance. Case-level evidence limits certainty.

Clinical relevance: Moderate
View original article →
NDT

IgG4-related kidney disease: treatment standard.

2026 Oct | Clinical review | DOI: 10.1093/ndt/gfag235

AI Clinical Summary

Glucocorticoids remain first-line induction; relapse and toxicity may favor rituximab maintenance. Phenotype-specific management and long-term monitoring are important.

Clinical relevance: High
View original article →
CJASN

Contemporary Approaches to Kidney Dysfunction and Diuretic Resistance in Acute Decompensated Heart Failure.

2026 Oct | Narrative review | DOI: 10.2215/CJN.0000001238

AI Clinical Summary

Stepped diuretics, combination therapy, and urinary response monitoring are central. Acute eGFR declines may be benign when decongestion succeeds, requiring clinical context.

Clinical relevance: High
View original article →
JASN

Comparative Cardiovascular Outcomes of Lanthanum Carbonate and Sevelamer in Dialysis.

2026 Oct | Target trial emulation cohort study | DOI: 10.1681/ASN.0000001289

AI Clinical Summary

Lanthanum was associated with lower MACE and mortality than sevelamer, but the observational design leaves potential unmeasured confounding.

Clinical relevance: High
View original article →
NephroHub
Educational literature summary for nephrology professionals. Always consult the original publication and current clinical guidance.